| Alfonso D'acunto, MD | |
|
301 E Main St, Anesthesia Department, Bay Shore, NY 11706-8408 | |
| (631) 968-3163 | |
| Not Available |
| Full Name | Alfonso D'acunto |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology |
| Experience | 44 Years |
| Location | 301 E Main St, Bay Shore, New York |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1922034263 | NPI | - | NPPES |
| 01640688 | Medicaid | NY | |
| 050060376 | Other | RAILROAD MEDICARE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | 157932 (New York) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Ns/lij Hs Southside Hospital | Bay shore, NY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| North Shore - Lij Anesthesiology, Pc | 1153602453 | 779 |
News Archive
iCo Therapeutics Inc. (the "Company") is pleased to announce that further to its press release issued October 20, 2009 announcing a $4,000,000 brokered private placement (the "Offering") co-led by Loewen, Ondaatje, McCutcheon Limited and Versant Partners Inc. (collectively, the "Agents"), the Company has completed the first tranche of the Offering through the issuance of 6,000,000 common shares of Company (the "Shares"). The Shares were issued at a price of $0.48 per share for gross proceeds of $2,880,000.
Researchers have discovered that the structure of human bones is vastly different than previously believed - findings which will have implications for how some debilitating bone disorders are treated.
Researchers examined cases of SARS-CoV-2 infection in fully and partially vaccinated healthcare workers, finding that vaccination provided strong immunity to the virus even though VOCs are on the rise in the non-vaccinated community at large.
ZIOPHARM Oncology, Inc., a biopharmaceutical company that is seeking to develop and commercialize a diverse, risk sensitive portfolio of in-licensed cancer drugs addressing unmet medical needs, announced today its financial results for the fourth quarter and full year 2009, and the filing of its Annual Report on Form 10-K with the Securities and Exchange Commission.
Idiopathic pulmonary fibrosis (IPF) is a scarring disease without a cure, irreparably damaging the ability of the tissue to transfer oxygen into the bloodstream.
› Verified 4 days ago
| Entity Name | North Shore - Lij Anesthesiology, Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1417401266 PECOS PAC ID: 1153602453 Enrollment ID: O20161228001498 |
News Archive
iCo Therapeutics Inc. (the "Company") is pleased to announce that further to its press release issued October 20, 2009 announcing a $4,000,000 brokered private placement (the "Offering") co-led by Loewen, Ondaatje, McCutcheon Limited and Versant Partners Inc. (collectively, the "Agents"), the Company has completed the first tranche of the Offering through the issuance of 6,000,000 common shares of Company (the "Shares"). The Shares were issued at a price of $0.48 per share for gross proceeds of $2,880,000.
Researchers have discovered that the structure of human bones is vastly different than previously believed - findings which will have implications for how some debilitating bone disorders are treated.
Researchers examined cases of SARS-CoV-2 infection in fully and partially vaccinated healthcare workers, finding that vaccination provided strong immunity to the virus even though VOCs are on the rise in the non-vaccinated community at large.
ZIOPHARM Oncology, Inc., a biopharmaceutical company that is seeking to develop and commercialize a diverse, risk sensitive portfolio of in-licensed cancer drugs addressing unmet medical needs, announced today its financial results for the fourth quarter and full year 2009, and the filing of its Annual Report on Form 10-K with the Securities and Exchange Commission.
Idiopathic pulmonary fibrosis (IPF) is a scarring disease without a cure, irreparably damaging the ability of the tissue to transfer oxygen into the bloodstream.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Alfonso D'acunto, MD Po Box 29140, South Bay Anesthesia, New York, NY 10087-9140 Ph: (800) 720-1664 | Alfonso D'acunto, MD 301 E Main St, Anesthesia Department, Bay Shore, NY 11706-8408 Ph: (631) 968-3163 |
News Archive
iCo Therapeutics Inc. (the "Company") is pleased to announce that further to its press release issued October 20, 2009 announcing a $4,000,000 brokered private placement (the "Offering") co-led by Loewen, Ondaatje, McCutcheon Limited and Versant Partners Inc. (collectively, the "Agents"), the Company has completed the first tranche of the Offering through the issuance of 6,000,000 common shares of Company (the "Shares"). The Shares were issued at a price of $0.48 per share for gross proceeds of $2,880,000.
Researchers have discovered that the structure of human bones is vastly different than previously believed - findings which will have implications for how some debilitating bone disorders are treated.
Researchers examined cases of SARS-CoV-2 infection in fully and partially vaccinated healthcare workers, finding that vaccination provided strong immunity to the virus even though VOCs are on the rise in the non-vaccinated community at large.
ZIOPHARM Oncology, Inc., a biopharmaceutical company that is seeking to develop and commercialize a diverse, risk sensitive portfolio of in-licensed cancer drugs addressing unmet medical needs, announced today its financial results for the fourth quarter and full year 2009, and the filing of its Annual Report on Form 10-K with the Securities and Exchange Commission.
Idiopathic pulmonary fibrosis (IPF) is a scarring disease without a cure, irreparably damaging the ability of the tissue to transfer oxygen into the bloodstream.
› Verified 4 days ago
Josette Legaspi-tamayo, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 301 E Main St, Anesthesia Department, Bay Shore, NY 11706 Phone: 631-968-3163 | |
Dr. Margaret Sagsveen, D.O. Anesthesiology Medicare: May Accept Medicare Assignments Practice Location: 301 E Main St, Bay Shore, NY 11706 Phone: 631-885-3885 | |
Mitchell Oldshein, M.D. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 301 E Main St, Anesthesia Department, Bay Shore, NY 11706 Phone: 631-968-3163 | |
Brittany Lee Mulligan, CRNA Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 301 E Main St, Bay Shore, NY 11706 Phone: 631-968-3000 | |
Alexander Shukis, M.D. Anesthesiology Medicare: Medicare Enrolled Practice Location: 301 E Main St, Anesthesia Department, Bay Shore, NY 11706 Phone: 631-968-3163 | |
Dr. Jaspreet Singh Toor, D.O. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 340 Howells Rd, Bay Shore, NY 11706 Phone: 833-547-7463 Fax: 631-248-5583 | |
Ronald R Perrone, M.D. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 375 E Main St, Bay Shore, NY 11706 Phone: 631-968-8288 |